These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7563917)

  • 1. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
    Shoji S; Miyake K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):997-1000. PubMed ID: 7563917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis C with different regimens of interferon].
    Yamauchi M; Nakajima H; Mizuhara Y; Toda G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):991-6. PubMed ID: 7563916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
    Fukuda A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic hepatitis C.
    Nelson DR; Davis GL
    Compr Ther; 1997 Apr; 23(4):269-76. PubMed ID: 9167919
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral effect of interferon: the interferon in viral hepatitis.
    Castañeda Guillot C; Sotto Escobar A; López Saura P
    Rev Roum Virol; 1990; 41(3-4):171-9. PubMed ID: 1712225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum HCV-RNA for evaluation of interferon-readministration to the former non responders in chronic hepatitis C].
    Sata M; Tanikawa K
    Nihon Rinsho; 1994 Jul; 52(7):1804-9. PubMed ID: 7521422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of interferon re-therapy and its adaptation in chronic hepatitis C].
    Matsuo S; Ohnishi K; Fujiwara K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1012-6. PubMed ID: 7563658
    [No Abstract]   [Full Text] [Related]  

  • 8. [Factors related to response to interferon in chronic hepatitis C].
    Pérez Alvarez R
    Gastroenterol Hepatol; 1996 Apr; 19(4):217-23. PubMed ID: 8665363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications for combination interferon-ribavirin therapy in chronic hepatitis C].
    Blum HE
    Internist (Berl); 1998 Sep; 39(9):981. PubMed ID: 9788122
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver histology as a predictor of the response to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):975-80. PubMed ID: 7563913
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
    Sauleda S; Esteban JI; Altisent C; Puig L; Esteban R; Guardia J
    Thromb Haemost; 2000 Jun; 83(6):807-10. PubMed ID: 10896229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 14. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating children with chronic hepatitis C after malignancy in a single center.
    Ansari S; Vossogh P; Bateni F
    Pediatr Hematol Oncol; 2007 Dec; 24(8):641-3. PubMed ID: 18092256
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
    Abdelmalek MF; Liu C; Valentine JF
    Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
    [No Abstract]   [Full Text] [Related]  

  • 17. [HCV genotype as a predictor of response to IFN therapy in chronic hepatitis C].
    Ebata M; Fukuda Y; Koyama Y; Hayakawa T; Kumada T; Nakano S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):954-8. PubMed ID: 7563909
    [No Abstract]   [Full Text] [Related]  

  • 18. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C].
    Baba T; Makino R; Shibata M; Harada E; Mitamura K
    Nihon Rinsho; 1997 Mar; 55(3):625-30. PubMed ID: 9086771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus conference. Treatment of hepatitis C.
    Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES)
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B303-20. PubMed ID: 12180305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.